Announcements 2020-21
. 27.03.2021 Intimation of Closure of Trading Window
. 28.12.2020 lntimation of Closure of Trading Window
. 13.11.2020 Disclosure of Related Party Transactions for the half year ended September 30, 2020
. 13.11.2020 Notice/ lntimation regarding issue of Duplicate Share Certificates
. 12.11.2020 Received License to work a factory for SEZ unit
. 06.11.2020 Notice/ lntimation regarding issue of Duplicate Share Certificates
. 26.10.2020 Notice/ intimation regarding loss/ misplace of share certificate
. 19.10.2020 Product Registration in Cambodia
. 09.10.2020 Notice/ Intimation regarding loss/ misplace of Share Certificate
. 29.09.2020 lntimation of Closure of Trading Window
. 28.09.2020 Notice/ lntimation regarding issue of Duplicate Share Certificates
. 26.09.2020 Outcome of 20th Annual General Meeting held on September 26, 2020
. 14.09.2020 Notice/ lntimation regarding loss/ misplace of Share Certificate
. 09.09.2020 Renewal of letter of Approval for SEZ unit
. 04.09.2020 Launching of new store segment “DAVAINDIA AYURVEDA & WELLNESS” under brand DAVAINDIA
. 02.09.2020 Newspaper Advertisements for 20th Annual General meeting (‘AGM’) of the Company
. 27.08.2020 Newspaper Advertisements for Public Notice of 20th Annual General Meeting
. 25.08.2020 Notice convening 20th Annual General Meeting (AGM) of the Company
. 14.08.2020 Product Registration in Uzbekistan
. 07.08.2020 Product Registration in Uzbekistan
. 29.06.2020 lntimation of Closure of Trading Window
. 27.06.2020 Product Registration in Turkmenistan
. 23.06.2020 lntimation regarding amending Code of lnternal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by lnsiders and Code of Practices and procedures for Fair Disclosure of Unpublished Price Sensitive lnformation (the “Code”)
. 05.06.2020 Product Registration in Cambodia
. 01.06.2020 lmpact of COVID-19 on Company’s Business Operations
. 25.05.2020 Press Release – Zota Health Care’s efforts in combating with coronavirus
. 29.04.2020 Reply to the clarification sought on the announcement dated April 28, 2020
. 28.04.2020 Launched new product with the name “COROVYL” for Viral lnfection
. 03.04.2020 Disclosure under Regulation 30(1), 30(2) and 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for the year ended on March 31, 2020